PubRank

H Fechner

Author PubWeight™ 14.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther 2010 1.16
2 Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med (Berl) 2006 1.12
3 Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001 1.09
4 Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction. Gene Ther 2007 0.98
5 HDL is the major source of vitamin E for type II pneumocytes. Free Radic Biol Med 1999 0.93
6 Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. J Mol Cell Cardiol 2012 0.91
7 Involvement of p32 and microtubules in alteration of mitochondrial functions by rubella virus. J Virol 2011 0.88
8 Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter. Circulation 2000 0.88
9 Regulation by vitamin E of the scavenger receptor BI in rat liver and HepG2 cells. J Lipid Res 2000 0.86
10 Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Eur J Hum Genet 1999 0.83
11 Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy. Z Kardiol 2002 0.82
12 Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism. Eur J Biochem 1998 0.81
13 Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Mol Med (Berl) 2005 0.80
14 Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements. Curr Pharm Des 2010 0.79
15 Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury. J Mol Med (Berl) 2006 0.78
16 Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo. Gene Ther 2006 0.78
17 A nucleotide deletion causing a translational stop in the protease reading frame of bovine leukaemia virus (BLV) results in modified protein expression and loss of infectivity. J Vet Med B Infect Dis Vet Public Health 2000 0.75
18 Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives. Z Kardiol 2004 0.75
19 [Polymerase chain reaction (PCR) for detection of BLV provirus-- a practical complement for BLV diagnosis?]. Berl Munch Tierarztl Wochenschr 1998 0.75
20 [Possibilities and limitations for use of the polymerase chain reaction (PCR) in the diagnosis of bovine leukemia virus (BLV) infection in cattle]. Dtsch Tierarztl Wochenschr 1998 0.75
21 New therapeutics targets in chronic viral cardiomyopathy. Ernst Schering Res Found Workshop 2006 0.75